As in young DEN-challenged mice (Fig. 6A), ATF4 ablation enhanced HCC development, and compared with AAV8-mCherry transduction, AAV8-xCT transduction significantly reduced both tumour number and tumour size (Fig. S7C and D). The gene discussed is ATF4; the disease is hepatocellular carcinoma.